Evidence map›Paper›PMID 35140269›Full record

ArticleScientific reports2022

Sox9 is involved in the thyroid differentiation program and is regulated by crosstalk between TSH, TGFβ and thyroid transcription factors.

Arístides López-Márquez, Carlos Carrasco-López, Andrea Martínez-Cano, Pascale Lemoine, Christophe E Pierreux, Pilar Santisteban

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Arístides López-MárquezInstituto de Investigaciones Biomédicas "Alberto Sols". Consejo Superior de Investigaciones Científicas (CSIC) y Universidad Autónoma de Madrid (UAM), CSIC-UAM., C/Arturo Duperier 4, 28029, Madrid, Spain.
Carlos Carrasco-LópezInstituto de Investigaciones Biomédicas "Alberto Sols". Consejo Superior de Investigaciones Científicas (CSIC) y Universidad Autónoma de Madrid (UAM), CSIC-UAM., C/Arturo Duperier 4, 28029, Madrid, Spain.
Andrea Martínez-CanoInstituto de Investigaciones Biomédicas "Alberto Sols". Consejo Superior de Investigaciones Científicas (CSIC) y Universidad Autónoma de Madrid (UAM), CSIC-UAM., C/Arturo Duperier 4, 28029, Madrid, Spain.
Pascale LemoineCell Biology Unit, de Duve Institute and Université Catholique de Louvain, 1200, Brussels, Belgium.
Christophe E PierreuxCell Biology Unit, de Duve Institute and Université Catholique de Louvain, 1200, Brussels, Belgium.
Pilar SantistebanInstituto de Investigaciones Biomédicas "Alberto Sols". Consejo Superior de Investigaciones Científicas (CSIC) y Universidad Autónoma de Madrid (UAM), CSIC-UAM., C/Arturo Duperier 4, 28029, Madrid, Spain. psantisteban@iib.uam.es.
Centro de Investigación Biomédica en Red de Cáncer · ESConsejo Superior de Investigaciones Científicas · ESde Duve Institute · BEHospital Sant Joan de Déu Barcelona · ESInstituto de Investigaciones Biomédicas Sols-Morreale · ESUCLouvain · BE

Funding

TREATMENT UTILIZATION AND TREATMENT NEEDSR01DA003724 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI BRUNSWICK, ANN F · 1985 to 1986
–
6 · The paper itself

Abstract

While the signaling pathways and transcription factors involved in the differentiation of thyroid follicular cells, both in embryonic and adult life, are increasingly well understood, the underlying mechanisms and potential crosstalk between the thyroid transcription factors Nkx2.1, Foxe1 and Pax8 and inductive signals remain unclear. Here, we focused on the transcription factor Sox9, which is expressed in Nkx2.1-positive embryonic thyroid precursor cells and is maintained from embryonic development to adulthood, but its function and control are unknown. We show that two of the main signals regulating thyroid differentiation, TSH and TGFβ, modulate Sox9 expression. Specifically, TSH stimulates the cAMP/PKA pathway to transcriptionally upregulate Sox9 mRNA and protein expression, a mechanism that is mediated by the binding of CREB to a CRE site within the Sox9 promoter. Contrastingly, TGFβ signals through Smad proteins to inhibit TSH-induced Sox9 transcription. Our data also reveal that Sox9 transcription is regulated by the thyroid transcription factors, particularly Pax8. Interestingly, Sox9 significantly increased the transcriptional activation of Pax8 and Foxe1 promoters and, consequently, their expression, but had no effect on Nkx2.1. Our study establishes the involvement of Sox9 in thyroid follicular cell differentiation and broadens our understanding of transcription factor regulation of thyroid function.

Indexed as

AnimalsCell DifferentiationCell LineCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinForkhead Transcription FactorsGene Expression RegulationMicePAX8 Transcription FactorPromoter Regions, GeneticSignal TransductionSOX9 Transcription FactorThyroid Epithelial CellsThyroid GlandThyroid Nuclear Factor 1Creb1 protein, mouseCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinForkhead Transcription FactorsFoxe1 protein, mouseNkx2-1 protein, mousePax8 protein, mousePAX8 Transcription FactorSox9 protein, mouseSOX9 Transcription FactorThyroid Nuclear Factor 1ThyrotropinTranscription FactorsTransforming Growth Factor beta

Identifiers

PMID35140269
PMCPMC8828901
OpenAlexW4210889045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.